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Abstract
Major histocompatibility complex class II (MHC-II) genes are fundamental components that contribute to adaptive immune
responses. While characterization of the chromatin features at the core promoter region of these genes has been studied,
the scope of histone modifications and the modifying factors responsible for activation of these genes are less well defined.
Using the MHC-II gene HLA-DRA as a model, the extent and distribution of major histone modifications associated with
active expression were defined in interferon-c induced epithelial cells, B cells, and B-cell mutants for MHC-II expression. With
active transcription, nucleosome density around the proximal regulatory region was diminished and histone acetylation and
methylation modifications were distributed throughout the gene in distinct patterns that were dependent on the
modification examined. Irrespective of the location, the majority of these modifications were dependent on the binding of
either the X-box binding factor RFX or the class II transactivator (CIITA) to the proximal regulatory region. Importantly, once
established, the modifications were stable through multiple cell divisions after the activating stimulus was removed,
suggesting that activation of this system resulted in an epigenetic state. A dual crosslinking chromatin immunoprecipitation
method was used to detect histone modifying protein components that interacted across the gene. Components of the
MLL methyltransferase and GCN5 acetyltransferase complexes were identified. Some MLL complex components were found
to be CIITA independent, including MLL1, ASH2L and RbBP5. Likewise, GCN5 containing acetyltransferase complex
components belonging to the ATAC and STAGA complexes were also identified. These results suggest that multiple
complexes are either used or are assembled as the gene is activated for expression. Together the results define and illustrate
a complex network of histone modifying proteins and multisubunit complexes participating in MHC-II transcription.
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Introduction
Antigen presentation is a paramount step in achieving adaptive
immunity, where the major histocompatibility class II complex
(MHC-II) proteins play a central role. The significance of MHC-II
complexes is best illustrated in cases of bare lymphocyte syndrome
(BLS) as patients that are unable to express MHC-II suffer from
various bacterial and viral infections and usually do not survive
beyond childhood [1]. MHC-II proteins display antigenic peptides
sampled from the endocytic compartments of the cell onto the cell
surface; these peptides typically originate from extracellular
pathogens but can include self, viral, or cancer-cell derived
peptides. Recognition of MHC-II-peptide complexes by CD4 T
cells triggers the expansion and differentiation of these T cells,
leading to a host of antigen-specific immune responses [2]. Proper
expression of MHC-II proteins both spatially and temporally is
critical, as aberrant expression can lead to an insufficient immune
response or autoimmunity [3].
MHC-II genes are expressed constitutively in professional
antigen presenting cells and thymic epithelial cells, and can also
be induced in most other cell types following treatment with
interferon-c (IFN-c) [4,5]. Cell-type dependent expression is
largely controlled by regulation of a limiting transcription factor,
the class II transactivator (CIITA) [6]. MHC-II genes share a
highly conserved proximal upstream promoter region called the
WXY box, where the factors RFXAP/B/5, CREB, and NF-Y
bind directly, forming a scaffold that is recognized by CIITA [7,8].
This unique DNA-protein structure is collectively called the
MHC-II enhanceosome [9]. The RFX proteins and CIITA are
essential for MHC-II expression, as genetic deficiencies in these
proteins leads to a MHC-II null phenotype and BLS [1]. Located
approximately 2.4 kb upstream of the transcription start site
resides another WXY element that is fully functional. Initially
described as a locus control element [10] and later termed XL4 for
conserved homology with the WXY sequence [11], XL4 binds
RFX and CIITA. Although the exact mechanism is unknown, it
was proposed that XL4 regulates HLA-DRA through a looping
mechanism [11]. No other distal regulatory elements were
reported to regulate HLA-DRA. CIITA also interacts with a
multitude of coactivating factors and general transcription factors,
which are recruited to the promoter to fine-tune the expression of
MHC-II genes (reviewed in [12]). It has been previously shown by
chromatin immunoprecipitation (ChIP) that multiple histone
acetylation modifications and active methylation marks increased
with constitutive and induced MHC-II expression at the proximal
conserved promoter regions of some MHC-II genes, suggesting a
role for these marks in regulation of this system.
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cations to be assigned an activating role in gene transcription, and
were initially described to be localized at promoter regions, as well
as enhancer and insulator elements of most genes [13,14]. A well
characterized histone lysine acetyltransferase (KAT) CREB-
binding protein (CBP) is recruited to MHC-II genes through
interactions with the N terminus of CIITA and possibly with
phosphorylated CREB that is bound at the promoter [15,16,17].
CBP and its homologue p300 are capable of acetylating all core
histones but have a preference for histone H4K5 and K8 when
tested with mononucleosomes in vitro but can also acetylate (ac)
histone H3K14 and K18 [18,19]. Another group of well-studied
histone acetyltransferases of the GNAT family, PCAF (p300/CBP-
associated factor) and GCN5 (general control nonderepressible 5),
have a preference for histone H3 with specificity for H3K14 and
H4K8 in vitro. PCAF and GCN5 have an expanded specificity for
histone H3K9, K14, K18, K23, and K27 in vivo, depending on
the complex of proteins with which they are incorporated
[19,20,21]. GCN5 and PCAF are also recruited to the promoter
of MHC-II genes [22]. PCAF has been shown to acetylate CIITA,
altering its nuclear localization as a mechanism to regulate MHC-
II transcription [23]. It has been shown previously that there is an
accumulation of multiple acetylation marks on histone H3K9,
K18, K27, and K14, as well as H4K5 and K8 in wild-type B cells
and in non-myeloid cells with IFN-c induction [24,25]. The level
of H3K18ac was affected when recruitment of CBP was reduced
at the DRA promoter due to knockdown of the proteasome
component Sug1 [26]. However, the same treatments did not
affect histone H3K9ac, suggesting a requirement for an indepen-
dent (or redundant) KAT complex to catalyze this modification
[26]. While KATs may have the capability to acetylate diverse
residues, they have a very restricted specificity in vivo, and by
determining the various modifications that occur, it may be
possible to identify the factors responsible for the modifications
and their regulatory roles in transcription. Additionally, a number
of complexes containing the same KATs have been described,
with each complex likely having specificity for individual genes
regulating distinct pathways. In the case of MHC-II genes, it is not
known which complexes are actually bound.
Methylation of histones can cause varied outcomes depending
on the modified residue and number of methyl groups [27]. The
most well studied active transcription methylation marks are those
of histone H3K4, where the three different levels of H3K4
methylation (me) have been shown to be associated with different
regulatory functions and areas of the genome. In reference to the
transcriptional start site (TSS), histone H3K4me3 (trimethylation)
is associated with actively transcribed genes and focused to a
narrow region immediately around the TSS. Histone H3K4me2
(dimethylation) has a broader deposition over the TSS that trails
into the coding region and has been regarded as the ‘open’
chromatin mark, suggesting that the region is accessible but not
necessarily transcribed. H3K4me1 (monomethylation) has attract-
ed attention as the mark of enhancers and other regulatory
elements, but is also found within the coding region of transcribed
genes [28]. Several groups have shown H3K4me2/3 (di and tri),
H3R17me2, K36me2/3, and K79me2, all marks associated with
transcriptionally active genes, to be induced with HLA-DRA
expression, as well as loss of silencing marks H3K9me2/3 and
H3K27me3 [11,25,29,30,31].
The first identified H3K4 methylating enzyme was Set1 (SET
domain containing 1) in yeast as a subunit of a multipartite
complex called COMPASS (Complex Proteins Associated with
Set1) [32,33]. Set1 and its human counterpart MLL1 (mixed
myeloid leukemia) are both homologs of Drosophila trithorax, well
known for its histone H3K4 methylating activity and role in the
positive regulation of homeobox genes during development [34].
Proteins of the MLL core complex have been shown to bind and
promote H3K4 methylation at the HLA-DRA promoter [35], and
intriguingly, interaction between MLL and PML (promyelocytic
leukemia) has been shown to prolong the dimethylation state of
H3K4 and maintain transcriptional memory by localization to
PML nuclear bodies [36]. Collectively, these data support the
possibility of an MLL/COMPASS type histone lysine methyl-
transferase (KMT) complex having a role in MHC-II regulation.
While we have a basic understanding of some of the key
promoter proximal histone modifications and some of the factors
involved, we do not know the overall distribution of these
modifications and factors, their stability or complexity, nor do
we fully understand their dependence on CIITA. To further define
the role of the major histone modifications associated with
transcriptional activation to this gene, we assessed the levels of
various modifications across the HLA-DRA MHC-II gene in
constitutive and inducible cell systems. Using a dual crosslinking
ChIP protocol to increase the radius of crosslinking and
interaction capture, the observed histone modifications were
correlated with the binding of specific coactivator/histone
modifying complexes that are constitutively present or recruited
to the locus upon induction with IFN-c. The results showed that a
multitude of factors, including those that make up the MLL
complex and complexes containing GCN5 and PCAF, are
involved at the HLA-DRA gene and are likely associated with
regulating its expression.
Materials and Methods
Cell Lines
The human Burkitt’s lymphoma cell line, Raji, was purchased
from the American Type Culture Collection (Manassas, VA) [37],
RJ2.2.5 cells are a CIITA-deficient cell line derived from Raji by
c-irradiation mutagenesis [6,38], and SJO cells are an RFX5-
deficient cell line isolated from a BLS patient [39,40,41]. RJ2.2.5
and SJO are MHC-II negative. SJO cells were generously
provided by Dr. J. Gorski (Wisconsin Blood Center), and
RJ2.2.5 cells were provided by Dr. R. Acolla (University of
Insurbia, Italy). The above cell lines were cultured in RPMI
supplemented with 5% fetal bovine serum, 5% bovine calf serum,
100 U/ml penicillin, and 100 mg/ml streptomycin. A431, a
human epithelial cell line, was obtained from ATCC and cultured
in Dulbecco’s Modified Eagle’s Medium with 10% fetal bovine
serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. A431
cells were treated with 500 U/ml IFN-c (PeproTech, Inc., Rocky
Hill, NJ) for 24 hrs when indicated to induce the expression of
CIITA and HLA-DRA. In some experiments, IFN-c treated cells
were washed with growth media and cultured in IFN-c-free media
for the indicated time.
qPCR and Primers
For all real-time quantitative PCR reactions, Bio-Rad iCycler
instruments (Bio-Rad Laboratories, Inc., Hercules, CA) with an iQ
optical module were used to measure the amount of SYBR
incorporated amplicons. DNA oligonucleotides used for primers
listed in Table 1 were purchased from Integrated DNA
Technologies, Inc. (Coralville, IA) and diluted to a final
concentration of 100 nM for PCR reactions. All primers were
tested by agarose gel electrophoresis to ensure that they formed
single amplicon products of the correct size and optimized for Tm
by temperature gradient real-time PCR followed by a melt curve
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quantify the amount of starting material for every PCR reaction.
mRNA Extraction and RT-PCR
IFN-c treated and untreated A431 cells were grown until they
were 80% confluent and RNA was prepared from cell pellets using
the RNeasy kit (Qiagen, Venlo, Netherlands) according to
manufacturer’s recommendations. 2 mg of total mRNA was used
in reverse transcription reactions using Superscript II (Life
Technologies Corp., Carlsbad, CA) with oligo dT and random
hexamer primers (Life Technologies Corp., Carlsbad CA).
Transcript specific primers (Table 1) were tested to produce single
amplicon products prior to the qPCR reaction. Real-time PCR
data were normalized to GAPDH mRNA expression using the
DDCt method [42]. All experiments were conducted at least three
times from independent cell cultures and statistical significance
was determined by Student’s t-test.
Chromatin Immunoprecipitation (ChIP)
For ChIP of histones, a conventional procedure was used as
described [24]. For suspension cells, 4610
7 cells were crosslinked
by 1% formaldehyde for 10 min. Adherent cells were plated the
previous day onto two 15 cm plates such that they would be 80%
confluent 16–24 hrs later when formaldehyde is applied. Follow-
ing crosslinking, chromatin was sonicated until the majority of it
was reduced to 200–600 bp fragments using the Bioruptor water
bath sonicator (Diagenode, Denville, NJ) and the amount of
chromatin DNA was measured using the Bio-Rad VersaFluor
Fluorometer (Bio-Rad Laboratories, Inc., Hercules, CA). 10 mgo f
chromatin and 2.5 mg of antibodies were used per ChIP assay.
10% of each IP was used for each subsequent PCR reaction.
Antisera were purchased from various manufacturers as follows:
anti-H3, H3K18ac, H3K4me1 (Abcam plc., Cambridge, United
Kingdom), H3K9ac, H3K27ac, H4K16ac, H3K4me2, H3K4me3
(Millipore Corporation, Billerica, MA). A polyclonal anti-T cell
receptor (TCR) antibody was used as a non-specific negative
control antibody in the histone ChIP experiments. All data were
presented as the percent of the input chromatin. Figures 1 and 2
were presented as unnormalized data, whereas the same data
presented in Figures S1 and S2 were normalized to the levels of
unmodified histone H3 at each amplicon.
For non-histone proteins, a secondary crosslinker was used in
addition to formaldehyde. Disuccinimidyl glutarate [43] (DSG,
Proteochem, Denver, CO) was applied to cells at 2 mM in Sodium
phosphate buffer (pH 8.0) for indicated times at room tempera-
ture. 1% formaldehyde was added to cells for the last 10 min of
crosslinking with the DSG. All successive steps were identical to
conventional ChIP. Except for the time course experiment in
Figure 3A, all DSG treatments were carried out for 20 minutes.
30 mg of chromatin was immunoprecipitated with 5 mg of anti-
CBP, p300, GCN5, PCAF, MLL1 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA), ASH2L, RbBP5 (Bethyl Laboratories, Inc.,
Montgomery, TX), ATAC2, YEATS2, NC2-b, TRRAP, TA-
DA1L, WDR5 (Abcam plc., Cambridge, United Kingdom), and
DPY-30 (Abnova, Taipei, Taiwan). Anti-CIITA antibodies were
prepared as previously described [44]. ADA2a and ADA2b
antibodies were a generous gift from Dr. R.G. Roeder at The
Rockefeller University [45]. Unimmunized control rabbit IgG
(Millipore Corporation, Billerica, MA) was used as a non-specific
negative control antibody for all transcription factor/complex
ChIP assays. The mean and standard error from these assays were
provided as percent input of the chromatin added. For all ChIP
assays, the Student’s t-test was applied to determine statistical
significance and all experiments were repeated at least three times
with separate cell culture preparations.
siRNA Treatment and Immunoblotting
Raji cells were split the previous day to allow the cells to grow in
log phase and collected the next day for nucleofection. ON-
TARGET plus SMARTpool siRNA for non-targeting control,
GCN5, MLL1, and WDR5 were purchased from Dharmacon
(Thermo Fisher Scientific Inc., Waltham, MA) and resuspended in
nuclease free water. Using the Amaxa Nucleofection kit V (Lonza,
Basel, Switzerland) 1610
6 cells were transfected with each
indicated pool of siRNA [100 nM] and cultured for 72 hrs. These
siRNA transfected cells were either collected for immunoblot,
RNA analysis, or ChIP. For immunoblotting, cells were washed
with PBS and lysed with RIPA buffer (25 mM Tris pH 7.6,
150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS)
Table 1. DNA oligos used in real-time PCR reactions.
Primer forward reverse
CIITA* 59-CTGAAGGATGTGGAAGACCTGGGAAAGC 59-GTCCCCGATCTTGTTCTCACTC
HLA-DRA* GAGTTTGATGCTCCAAGCCCTCTCCCA CAGAGGCCCCCTGCGTTCTGCTGCAAT
GAPDH* CCATGGGGAAGGTGAAGGTCGGAGTC GGTGGTGCAGGCATTGCTGATG
XL4 CAGAGAAAGGGAACTGAAAGTCATTT TTATGACACTGTTTAGTCCTAGAACACTGA
22000 CAACAACTTGGATTGAAGATGC AGGTAAAGAGTCAGGAGAATGG
2600 ATGAGATACAATGCCAGCCATCC ACAGTTGGAGAGTTTGCGTAAGG
2300 TGTCCCTTACGCAAACTCTCC ACACAAGATACTCCGTTCATTGG
WXY GATCTCTTGTGTCCTGGACCCTTTGCAAGAACCCT CCCAATTACTCTTTGGCCAATCAGAAAAATATTTTG
+300 GGACGATAGACTACGAAGCATTGG TGACTTACTTCAGTTTGTGGTGAGG
+600 AGCCCTGTTCTTATCTGAATACATG GCCTTCCCTCCCCTTTTCC
+1500 CTCCGTCTCAAACAACCAAACC ACCAACACCAAGGGAATAATGAAC
+3500 TTCCGCAAGTTCCACTATCTCC CGAGTTTCACACAAGCATCATAGG
+5800 AGGTAAAGAGTCAGGAGAATGG ATGATACAGCCAAGATGAAACC
*Primers used for Reverse Transcription PCR reactions.
doi:10.1371/journal.pone.0037554.t001
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measured using the Bio-Rad protein assay reagent (Bio-Rad
Laboratories, Inc., Hercules, CA) and equal amounts of lysate
protein were resolved on a polyacrylamide gel and transferred to a
PVDF membrane. Membranes were blocked with 5% non-fat
milk dissolved in TBS-Tween20 (0.01%) solution then probed with
each indicated antiserum. Antibodies to beta-actin (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) were used to portray sample
loading. HRP conjugated anti-mouse and anti-goat were from
Sigma-Aldrich Co. (St. Louis, MO), and anti-rabbit was from
Rockland Immunochemicals Inc. (Gilbertsville, PA), respectively.
Chemiluminescence signal was recorded on BioMax XAR film
(Kodak, Rochester, NY) and band intensities were measured using
ImageQuant TL program (GE healthcare, Piscataway, NJ).
Figure 1. IFN-c treatment induced the deposition of active histone modifications throughout the HLA-DRA gene. (A) RNA levels for
CIITA and HLA-DRA were measured by qRT-PCR. Transcript levels for A431 cells are shown before and after treatment with 500 U/ml of IFN-c for
24 hrs. The results of three independent experiments were averaged and plotted with standard error. (B) A schematic of the HLA-DRA gene and open
reading frame is illustrated with exons (black boxes) and introns (clear) indicated. The bars below the gene represent the relative position of the PCR
amplicons used. (C) ChIP and qPCR were conducted on untreated control (clear) or 24 hrs IFN-c treated (black) A431 cells using the indicated antisera
and amplicons described in B. The data are presented as an average of the percent input value derived from three to four biological replicates and
error bars represent standard error. For unmodified histone H3, the asterisk (*) indicates a Student’s t-test value of p,0.05 in comparing an upstream
region (2600) and the WXY box region with IFN-c treatment.
doi:10.1371/journal.pone.0037554.g001
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IFN-c Treatment Leads to Increased Active Histone Marks
at the HLA-DRA Locus
Histone modifications and the factors that place these marks are
responsible for the regulation of the chromatin state and may
influence the expression of a gene. Identification of potential factor
candidates can be obtained from an understanding of the presence
and distribution of the local chromatin modifications across the
locus. To generate this information, a series of ChIP assays were
conducted on cells that were induced for MHC-II gene expression,
as well as those that constitutively expressed the genes. The HLA-
DRA gene was used as the model MHC-II gene because it is
monomorphic and expressed at high levels. The A431 epithelial
cell line is negative for both CIITA and MHC-II gene expression.
Figure 2. MHC-II expressing B cells have active histone modifications distributed across the HLA-DRA gene. (A) The HLA-DRA gene
region and additional PCR amplicons (22000 and +5800) used in this and subsequent experiments are depicted. (B) Using the indicated antibodies,
the distribution of unmodified H3, CIITA, and modified histones at the HLA-DRA gene was analyzed by ChIP-qPCR for the amplicons described in A in
MHC-II expressing (Raji, black) and non-expressing (RJ2.2.5, CIITA-deficient, grey; SJO, RFX5-deficient, clear) B cell lines. The data are plotted as the
average of the percent input values from three biological replicates and error bars represent standard error. In the unmodified histone H3 panel, an
asterisk (*) indicates a Student’s t-test value of p,0.05 comparing the 2600 and 2300/WXY region, and double asterisks (**) indicate a t-test value of
p,0.01 between +300 and 2300/WXY in Raji cells.
doi:10.1371/journal.pone.0037554.g002
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37554Figure 3. Dual crosslinking enhances the pulldown efficiency of coactivators CBP and p300. (A) ChIP-qPCR was performed for CBP at the
HLA-DRA promoter region (WXY) and a negative control region (22000) after Raji cells were treated with disuccinimidyl glutarate (DSG) for the
indicated time together with the conventional formaldehyde crosslinking. Clear columns indicate the percent input values for control IgG pulldown
and black columns represent those for CBP. (B) ChIP-qPCR was performed for the indicated factors in Raji (black), RJ2.2.5 (grey; CIITA-deficient), and
SJO (clear; RFX5-deficient) cells. Amplicons tested by qPCR were as illustrated in Figure 2A. The values plotted are an average of three biological
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HLA-DRA genes ,300 and ,5,000 fold, respectively (Figure 1A).
To assess the distribution of histone modifications across the
HLA-DRA locus, a set of amplicons were designed along the length
of the HLA-DRA gene stretching from 22,500 to +3,500 bp
(Figure 1B), which included the upstream regulatory element (here
termed XL4) [10,11], to a region far downstream of the TSS.
Amplicons for 2300 and the major regulatory region, WXY box,
are immediately adjacent to each other (Figure 1B). The 2300
amplicon is where the first nucleosome 59 of the nucleosome free
region has been reported to be positioned [46]. ChIP analyses of
A431 cells (2/+ IFN-c) were performed using anti-CIITA and
various histone posttranslational modification specific antibodies
that are associated with active transcription (Figure 1C). CIITA
occupancy appeared only after IFN-c induction and showed a
sharp peak at the WXY and 2300 regions, which confirms that it
was indeed recruited to the HLA-DRA gene [8,24] in our assay,
and also that the resolution of the experiment was ,300 bp.
Analysis of unmodified histone H3 across the region showed minor
differences across the gene in the uninduced state. However,
following IFN-c induction the distribution of nucleosomes was
reduced at the WXY region compared to an upstream region
(2600) as previously described [46], suggesting that this region is
more accessible in the active state.
Histone lysine acetylation marks were examined for H3K9,
K18, K27, and H4 acetylation marks K8 and K16 (Figure 1C). In
the uninduced state, very low levels of these modifications were
observed, irrespective of the position across the gene. Following
IFN-c induction, a broad distribution of the acetylation marks
appeared. Histone H3K18 and K27 acetylation showed relatively
even distributions around the TSS and WXY box regions;
whereas H3K9 and H4K8 displayed different patterns with
H4K8 acetylation levels being higher upstream and H3K9
acetylation levels peaking at regions downstream from the TSS.
Histone acetylation levels of H3K14, K23, and H4K5, K12, and
K16 were also measured following IFN-c treatment. Very low to
no levels of these modifications were detected at the control or
induced time point (data not shown) as represented by H4K16ac
in Figure 1C. Thus these data point to H3K9 and H3K18 as the
dominant H3, and H4K8 as the dominant H4 acetylation
modifications associated with IFN-c induced HLA-DRA gene
expression. The levels of histone modifications in Figure 1C are
plotted irrespective of histone H3 concentrations, whereas Figure
S1 shows the same data normalized to the levels of histone H3
ChIP at each amplicon. Only slight differences in distribution over
the WXY and 2300 amplicons can be observed in comparing the
two figures; which reflect the change in nucleosome density
following IFN-c treatment.
As H3K4 methylation is associated with active transcription, the
three degrees of methylation were observed following IFN-c
treatment. H3K4me1 levels were significantly induced at all
regions except the WXY box and +300. Surprisingly, the 2600
amplicon showed high levels of the H3K4me1 modification. There
is no reported regulatory activity for this region at this time. The
finding of this modification may suggest a novel regulatory
element at this location. The mark for histone H3K4me2 showed
a broad distribution, but was clearly shifted downstream from the
TSS. H3K4me3, a mark of active transcription was more sharply
positioned around the TSS with a peak downstream of the TSS.
Significant levels of H3K4me1 and me2 modifications were also
found at the upstream XL4 element with IFN-c induction. It is
important to point out that the baseline levels of all the above
modifications are typically very low, suggesting that CIITA
occupancy is required for these modifications.
Active Histone Marks are CIITA and RFX5 Dependent in B
Cells at HLA-DRA
To determine if a constitutively expressing system would have a
similar histone modification distribution, a commonly used
Burkitt’s lymphoma B cell line, Raji, was examined. Raji cells
express high levels of CIITA and all MHC-II genes, including HLA-
DRA. To determine whether the above histone modifications were
dependent on the presence of CIITA or RFX5, ChIP assays using
CIITA- (RJ2.2.5) and RFX5- (SJO) deficient cell lines were
compared to Raji. RJ2.2.5 cells were derived from Raji cells by c-
irradiation and SJO cells were B cells established from a bare
lymphocyte syndrome patient [6,38]. The region of analysis was
expanded to +5800 with an additional amplicon at 22000. This
analysis encompasses the entire open reading frame of HLA-DRA
(Figure 2A).
In Raji cells, a high and tight peak of CIITA binding was
observed at the WXY region as expected (Figure 2B, [24]).
Nucleosome density measured by histone H3 presence was
variable between the three cells lines. In Raji cells, there is a
clear reduction in nucleosomes at the 2300/WXY region
compared to its surrounding areas; whereas the nucleosome
density in RJ2.2.5 or SJO cells did not show this preferential
depletion at the proximal promoter region (Figure 2B). This agrees
with the IFN-c induction data presented above, suggesting that
only in the active state does the chromatin structure of the
proximal promoter region become accessible.
The presence of the activation marks observed above was
examined in the three cell lines. Universally, all four acetylation
modifications were lower or absent in RJ2.2.5 and SJO cells
compared to Raji. As RJ2.2.5 cells do not make a functional
CIITA, and SJO cells do not bind CIITA due to a lack of RFX
binding, these data demonstrate that CIITA is required for these
modifications. In Raji cells, histone H3K9 and K18 acetylation
values were extremely high and were broadly distributed
extending upstream of the gene and only slightly into the open
reading frame. H3K27 and H4K8 levels were also high and
showed a similar distribution. In contrast to the IFN-c pattern,
XL4 showed higher levels of the histone H3 acetylation marks in B
cells, with the exception of H4K8ac, which had shown a relatively
high level following induction by IFN-c. As above, Figure 2 is
plotted irrespective of the nucleosome density; whereas Figure S2
is plotted with respect to the histone H3 levels for each amplicon.
While there are no major differences, histone modifications
associated with the WXY and 2300 regions are increased in Raji
cells when normalized to the lower levels of nucleosomes over
those sequences.
Histone H3K4 methylation showed distinct distributions among
the wild-type and mutant B-cell lines. Monomethylation was
strongest at the upstream XL4 site and the surrounding region in
all cell lines, which is indicative of this region functioning as an
enhancer-like element [14]. However, in Raji cells, monomethyla-
tion was markedly decreased at regions approaching the TSS,
disappearing at +300, and reappearing at +1500 bp downstream
of the TSS. In contrast monomethylation was higher at the +300
region in RJ2.2.5 and SJO cells and positioned evenly throughout
replicates and error bars represent standard error. The double asterisks (**) in A denote a Student’s t-test value of p,0.01 when compared to 0 min
DSG crosslinked values.
doi:10.1371/journal.pone.0037554.g003
Coactivator Complexes in HLA-DRA Expression
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37554the 2600 to +600 regions. No pronounced peak at 2600 was
observed in any of the cells. Histone H3K4me2 was broadly
distributed in Raji cells and lower at all regions in RJ2.2.5 and
SJO cells. The levels of H3K4me2 in SJO cells were significantly
lower than RJ2.2.5 at the WXY box, suggesting that the lack of
RFX binding to the region may be responsible for this additional
loss of this histone modification. Histone H3K4me3, as expected
showed sharp and high levels at regions close to the TSS in Raji
cells, with its highest level at +600. In RJ2.2.5, low levels of
H3K4me3 were observed close to the TSS. In contrast, no
H3K4me3 was observed in SJO cells, again pointing to the role of
RFX5 in assembly of the factors at the WXY box region [47].
Dual Crosslinking ChIP Increases Pulldown Efficiency
The spacer length of formaldehyde is limited to 2 A ˚, a distance
that allows for the ChIP assay to be optimal for DNA binding
proteins or their tightly interacting protein partners [48].
However, detection of coactivators, chromatin modifiers, or
factors that interact at a greater distance from the DNA may
not be as efficient under the standard conditions. To enhance the
pulldown efficiency of our ChIP assays for indirect DNA-protein
interactions, a dual crosslinking ChIP procedure was optimized
using disuccinimidyl glutarate (DSG), which has a crosslinking arm
of 7.7 A ˚ [43]. Using this dual crosslinking assay, detection of CBP,
a known coactivator that interacts with CIITA and binds to the
promoter [15,30], was significantly increased at the WXY box
(Figure 3A). The increase in CBP detection was time dependent,
and importantly, CBP binding was absent at a negative control
region (22,000) even at the longest time treatment of DSG. This
demonstrates that there is no increase in non-specific binding due
to the additional crosslinking step, while increasing the pulldown
efficiency more than 9 and 11-fold when cells were DSG
crosslinked for 20 or 30 min, respectively, compared to cells only
crosslinked with formaldehyde. Therefore, the DSG dual cross-
linking procedure was employed in subsequent ChIP assays to
examine coactivator proteins interactions with the HLA-DRA gene.
Additional controls were carried out across the region to assure
that backgrounds levels were not increased at each amplicon, and
previously reported coactivators could be captured (Figure 3B).
Using all three cell lines, CIITA, RFX5, CBP, p300, and control
IgG antisera were used in the dual crosslinking ChIP assays. The
results showed a slight broadening of CIITA and RFX5 binding at
the WXY/2300 regions. RJ2.2.5 showed RFX5 binding as before
[10] and SJO did not bind either factor. The dual crosslinking
procedure did however produce higher levels of these factors at
XL4. Control IgG levels were low at each amplicon. CBP and
p300 binding was also captured at the WXY through 2600
amplicons in Raji cells but not in RJ2.2.5 or SJO suggesting that
their recruitment was dependent on CIITA. This role of CIITA
recruiting these factors to the promoter region was reported
previously [15,16,22,30]. However, significant recruitment of CBP
and p300 were found at XL4 in all three cell lines, suggesting that
their recruitment to this region is independent of RFX5 and
CIITA.
The MLL Histone Methyltransferase Complex
Components are Enriched at Surrounding Regions
The MLL histone methyltransferase core complex consists of
MLL, WDR5, ASH2L, RbBP5, and DPY-30 [47]. Together these
proteins catalyze the addition of a methyl group to H3K4,
producing mono-, di-, and trimethylated H3K4 in vitro and in
vivo [47,49]. As there were high levels of all three methylation
states observed at different regions across the HLA-DRA gene,
ChIP assays were conducted on Raji, RJ2.2.5, and SJO chromatin
preparations to determine if these MLL complex core proteins
were present (Figure 4). It was expected that, because these factors
are part of a core complex that binding to the HLA-DRA locus,
would simply reflect the transcriptional activation state of the
locus. This was not the case. Whereas all five proteins were bound
across the locus in Raji cells, MLL1, ASH2L, and RbBP5 were
mostly dependent on the presence of RFX5, while showing slight
dependency on CIITA. DPY-30 was unique in that its binding was
completely RFX5 and CIITA dependent as binding was not
detected in either SJO or RJ2.2.5. WDR5 recruitment was
completely independent of RFX5 or CIITA due to the fact that its
level of occupancy was unchanged between the three cell types.
RFX and CIITA independent binding of some of these subunits
may explain why lower but significant levels of H3K4me2 were
observed in RJ2.2.5 cells when compared to Raji cells.
IFN-c induced A431 cells were also tested to determine the
binding of the above factors. CIITA and RFX5 ChIPs were
conducted initially to test the efficiency of dual crosslinking
pulldown in the IFN-c induced cells. CIITA binding was present
only in the IFN-c treated cells. The levels of pulldown achieved in
the inducible system was ,4 fold lower than in B cells at the WXY
box (Figure 5A). While there are low levels of RFX5 binding in the
resting A431 cells, they are induced more than 2 fold with IFN-c
treatment. This has been observed previously, and is due to
stabilization of the DNA binding components by CIITA [50,51].
Therefore, an increased level of coactivator binding can be due to
both the increased recruitment of RFX or CIITA. In uninduced
cells, only WDR5 displayed significant binding above the
background IgG control (Figure 5B). Following IFN-c treatment,
MLL1, WDR5, ASH2L and RbBP5 were associated with
sequences surrounding the TSS and at XL4. Surprisingly, DPY-
30 was not observed at the locus under any of the conditions
tested. Together, these results suggest that the MLL histone
methyltransferase components are being recruited to the HLA-
DRA locus most significantly at the promoter, but also within the
body of the gene and regulatory regions.
Histone Acetyltransferase Complexes Containing GCN5
and PCAF are Present throughout the Coding Region and
at Upstream Regulatory Elements
The lysine acetyltransferases (KAT) CBP and GCN5 have been
shown previously to bind the HLA-DRA promoter [22,26,30].
CBP, p300, and PCAF have been shown to interact directly with
CIITA [15,16,23,52]. To examine the breadth at which these
KATs interact across the locus and to correlate that with the
histone acetylation data, ChIP assays for these factors were carried
out in the three B cell lines described above. Thus, to determine
whether CIITA or RFX5 was indeed important in recruiting each
of these factors to the HLA-DRA locus the binding of the above
KATs in Raji, RJ2.2.5, and SJO cells were compared. There were
no major differences in the protein expression levels of these KATs
between the three cell lines as determined by immunoblot (Figure
S3). At the WXY box region, the presence of CIITA was critical
for CBP, p300, GCN5, and PCAF (Figures 3B and 6A), illustrating
the role CIITA plays in the recruitment of these KATs to the
locus. The binding of these KATs to XL4 was also CIITA
dependent. In agreement with the histone acetylation data
(Figure 2B), a high level of GCN5 and PCAF were observed at
the 2600 region. Moderate levels of GCN5 and PCAF, but not
CBP and p300, were associated within the coding region.
Recent studies in humans have defined two distinct GCN5/
PCAF containing complexes, termed STAGA and ATAC that
diverged from their shared common ancestor, the yeast SAGA
complex [53,54]. To determine which of these complexes might
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number of key subunits of each complex were conducted
(Figure 6B). For the ATAC complex, ADA2a, ATAC2, YEATS2,
and NC2-b were examined. The overall binding levels of these
components were low and may be due to antibody affinity. The
binding of ADA2a and YEATS2 displayed some level of binding
across the locus in Raji and RJ2.2.5 cells, suggesting that their
recruitment was dependent on RFX5 and CIITA. ATAC2
displayed statistically significant binding in all three cell types,
suggesting that its recruitment was independent of RFX5 and
CIITA. Binding of NC2-b was not detected for any of the regions.
For STAGA complexes, ADA2b, TRRAP, and TADA1L were
examined. ADA2b showed no statistical significance over back-
ground IgG in binding in any of the cell types (Figure 6B). TRRAP
and TADA1L were bound in all three cell types, with TRRAP
displaying significantly higher levels in Raji over RJ2.2.5 at several
of the loci examined. Thus, while the presence of ADA2a versus
ADA2b would suggest that the ATAC complex and not STAGA
was bound, components of each of these complexes could be found
associated with the HLA-DRA gene.
A similar analysis for the IFN-c treated A431 cells was also
conducted and is presented in Figure S4. Albeit at lower levels,
GCN5 was found at significant levels from 2600 through +3500
over background in both untreated and IFN-c treated cells. A
statistically significant increase in GCN5 was observed surround-
ing the promoter region (2300 through +300). Of the other factors
examined, only ATAC2, TRRAP, and TADA1L showed low but
statistically significant binding and this binding was not dependent
on IFN-c.
siRNA Knockdowns of GCN5 and MLL do not Affect
Transcription or Histone Modification Levels
To examine whether GCN5 or MLL play a non-redundant and
critical role in the regulation of HLA-DRA gene expression, siRNA
knockdowns of these proteins and WDR5 were conducted in Raji
cells. Compared to a control non-targeting Dharmacon SMART-
pool, siRNA SMARTpools to GCN5, MLL1, and WDR5 were
able to reduce the levels of their respective proteins between 50
and 80% (Figure 7A). Analysis of CIITA and HLA-DRA gene
mRNA levels at 3 days post transfection (Figure 7B) or 5 days post
transfection with a second siRNA transfection at 48 hrs after the
initial transfection (data not shown) showed no change in
expression of either gene. Consistent with this result was the
finding that histone H3K9ac, H3K18ac, H4K8ac, H3K4me2,
H3K4me3 levels were not altered and CIITA binding was not
affected (Figure 7C). A similar set of experiments conducted with
A431 fibroblasts 2/+ IFN-c treatment and the siRNAs also did
not provide a clear dependency on these factors for expression
(data not shown). Thus, although these factors are readily
detectable at the HLA-DRA gene, their roles are not essential to
expression, there are functionally redundant factors, or once the
gene is activated, the transcriptional complexes are stable.
Histone Modifications are Stably Present after Removal of
IFN-c
To address the possibility that once induced, the histone
modifications associated with HLA-DRA expression are stable,
A431 cells were treated with IFN-c for 24 hrs as in above
experiments, then washed and supplied with culture media free of
Figure 4. Histone methyltransferase MLL1 core complex
proteins are recruited to HLA-DRA in B cells. MLL core complex
proteins, MLL1, WDR5, ASH2L, RbBP5, and DPY-30 were assessed for
their binding across the HLA-DRA gene in Raji (black), RJ2.2.5 (CIITA-
deficient, grey), and SJO cells (RFX5-deficient, clear) by qPCR after DSG-
ChIP. The negative control IgG ChIP pulldowns conducted concurrently
with these experiments are shown in Figure 3B. The data represent the
average of the percent input values from the pulldown of each
indicated protein at each amplicon as indicated in Figure 2A. The values
are an average of 3–5 biological replicates and the error bars represent
the standard error. For RFX5-dependent factors, the asterisks represent
Student’s t-test values p,0.05 of statistical significance for comparisons
between RJ2.2.5 and SJO. For CIITA-dependent factors, the asterisks
represent Student’s t-test values p,0.05 between Raji and RJ2.2.5 cells.
doi:10.1371/journal.pone.0037554.g004
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course of these experiments the cells double at least once per day.
Within 24 hrs of IFN-c removal, CIITA mRNA levels were
substantially lower in these cells, whereas HLA-DRA mRNA levels
did not significantly change up to 72 hrs (Figure 8A). CIITA
binding at the HLA-DRA promoter was assessed by ChIP to
determine whether IFN-c removal also diminished recruitment of
CIITA (Figure 8B). After removal of IFN-c, CIITA levels at the
promoter gradually decreased to ,49% of the initial induction.
When histone modification levels were examined, none of the
modifications tested showed a significant reduction up to the 72 hr
time point. An additional set of experiments was carried out for 5
days after IFN-c removal. At this time point, CIITA and HLA-DRA
mRNA levels had fallen to ,7 and 400 fold over pre-stimulation
levels, respectively. CIITA binding to the HLA-DRA WXY region
was reduced by ,68%. Intriguingly, the histone modifications
were for the most part unchanged even at these later time points
(Figure 8B). These results illustrate the stability of CIITA binding
at the MHC-II promoters, as well as the stability of the histone
modifications.
Discussion
MHC-II genes, as a fundamental constituent of adaptive
immunity, are highly regulated at the transcriptional level. While
many essential cis-regulatory elements and transcription factors
have been determined, only a few coactivating transcription
factors have been identified. In this report, our efforts were focused
on determining the location and distribution of active histone
modifications associated with MHC-II gene transcription, and on
identifying histone modifying coactivating factors that were
recruited to the HLA-DRA gene, which served as a model
MHC-II gene. Along with histone modifications, the relative
nucleosome density was examined across the gene. For the most
part, the density was evenly distributed in cells that were not
expressing HLA-DRA. However, when HLA-DRA was expressed,
there was a notable decrease in the nucleosome density
immediately upstream of the TSS. This decrease was not seen in
either the CIITA- or RFX5-deficient cell lines or in control
fibroblasts. This suggests that CIITA recruitment was necessary
for altering the nucleosome density, and as discussed below, many
of the other chromatin modulating events at the locus. The
decrease in nucleosome density may maintain an accessible
chromatin environment close to the TSS to allow efficient
assembly of RNA polymerase components and subsequent
transcription initiation.
With activation of transcription, histone modifications associat-
ed with active gene expression were present to varying degrees and
patterns across the HLA-DRA locus. While the distribution patterns
of each mark were largely similar between the IFN-c induced cells
and B cells, minor differences were observed. The difference in
ChIP assay levels in general may reflect the difference between
newly applied histone modifications as in the case of IFN-c treated
A431 cells, and constitutive levels of the same histone modifica-
tions in the B cells. The levels of histone modification observed in
IFN-c treated cells imply that histone modifying factors were
newly recruited, whereas in both wild-type and mutant B cell lines,
Figure 5. MLL core complex proteins are recruited in IFN-c
treated cells. (A) Human epithelial A431 cells were treated with IFN-c
for 24 hrs and tested for the binding of CIITA and RFX5 to verify the
experimental procedure in the IFN-c inducible system. (B) MLL core
complex proteins were tested for binding before and after IFN-c
treatment in A431 cells. The data presented represent the average
percent input value at each amplicon (Figure 2A) after DSG-ChIP
pulldown of three biological replicates from untreated (clear) and IFN-c
treated (black) cells. The error bars represent the standard error.
Asterisks represent Student’s t-test values p,0.05 of the IFN-c treated
cells compared with background IgG controls for that amplicon.
doi:10.1371/journal.pone.0037554.g005
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modifications by constant new application and removal of the
marks. The dissimilarities of modification patterns were mostly at
the XL4 region, where higher levels of several modifications were
observed in B cells compared to IFN-c induced cells. H4K8ac was
an exception to this as it was higher at XL4 in the IFN-c induced
cells. These observations may reflect the potential for differential
use of XL4 as a regulatory element in the different cell types and
conditions. The data collected here suggest that XL4 is likely more
important for B-cell specific than for the IFN-c induced
expression. Alternatively, the use of XL4 may correlate with
higher levels of HLA-DRA transcription in Raji cells.
The three histone H3K4 methylation modifications had
markedly distinct distribution patterns across the HLA-DRA gene.
H3K4me3 was highly enriched in a focused region surrounding
and just downstream of the TSS in both IFN-c induced cells and B
Figure 6. GCN5 and PCAF containing histone acetyltransferases ATAC and STAGA are recruited to HLA-DRA. (A) Dual crosslinking ChIP-
qPCRs for histone acetyltransferases GCN5, and PCAF were conducted for regions across HLA-DRA in Raji (black), RJ2.2.5 (CIITA null, grey), and SJO
(RFX5 null, clear) cells as above. (B) Binding of the ATAC (ADA2a, ATAC2, YEATS2, NC2-b) and STAGA (ADA2b, TRRAP, TADA1L) complex subunits was
determined as in A. The average of percent input values from the DSG-ChIP for each indicated protein is shown with the values averaged from 3–5
biological replicates. The asterisks indicate a Student’s t-test value of p,0.05 at each amplicon when compared to the control IgG values for each cell
line.
doi:10.1371/journal.pone.0037554.g006
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biphasic peak surrounding the TSS [55]. Although diminished
significantly, H3K4me3 was present in the CIITA-deficient cell
line but not the RFX5-deficient line. Because the RFX-CREB-
NF-Y ternary complex is assembled in RJ2.2.5 cells [56], the data
suggest that these factors can at some level recruit the necessary
KMT to write this mark close to the TSS. A similar observation
was made for H3K4me2 as well. The H3K4me1 modification was
highest in both CIITA- and RFX5-deficient cells, indicating that
the factors bound in these cells are capable of recruiting the KMT
responsible for this modification. Thus, in the most basal state,
H3K4me1 is placed at the TSS region, and the assembly of the
RFX-CREB-NF-Y factors and subsequent CIITA recruitment
results in additional methylation of H3K4. The finding of any
modifications in SJO (RFX5-deficient) was unexpected as previous
reports had shown that in the absence of a functional RFX, the
other DNA binding factors (CREB and NF-Y) do not assemble
[57]. However, the finding of the histone modifications in SJO
cells could represent transient binding of NF-Y or CREB to these
sites with the subsequent recruitment of KAT/KMTs and
establishment of the observed histone modifications.
Intriguingly, in the HLA-DRA expressing B cells, there was an
enrichment of H3K4me1 at +1500 similar to the levels observed at
XL4 in all three B cell lines. While this mark is known to be present
within the body of genes [14], the +1500 did have significantly
more of this mark than surrounding areas, suggesting the
possibility of a novel regulatory region within the vicinity.
Twenty-four years ago, a paper reported that this region of the
HLA-DRA intron had tissue specific enhancer activity [58]. This
modification may reflect that activity. It is intriguing that the
modification was not observed in the CIITA- or RFX5-deficient
cells, suggesting that it is CIITA dependent. Similarly, in the IFN-
c induced fibroblasts H3K4me1 was enriched at 2600 compared
to the other sequences. This region has no known function at this
time, but like the +1500 region, could represent a novel control
element for this gene.
The addition of a secondary protein crosslinker to the standard
ChIP assay allowed the identification and demonstration of the
clear association of coactivators associated with the HLA-DRA
gene. The KATs CBP, p300, GCN5, and PCAF have been
previously described to associate with CIITA in cell lysates
[15,22,23], and CBP and GCN5 have been shown by ChIP to be
bound to HLA-DRA WXY box regions in MHC-II expressing cells
[30,31]. Here, each of these factors was shown to be recruited to
the HLA-DRA WXY box region in a CIITA- and RFX5-
dependent manner. Of the histone acetylation modifications
observed, H3K9ac and H3K18ac were the most prominent, and
these marks have been strongly associated with the KAT activities
of GCN5/PCAF and CBP/p300, respectively [59,60,61,62], and
are likely responsible for placing these marks on HLA-DRA.
In B cells, there were significantly higher levels of enrichment
within the body of the gene for GCN5 and PCAF, when compared
to CBP and p300. GCN5 has been shown to bind within the body
of genes and has been implicated in transcriptional elongation
[63,64]. Inducible genes can be heavily regulated at the elongation
step and GCN5 may be regulating transcription by acting as a
Figure 7. GCN5, MLL1, and WDR5 knockdown does not affect HLA-DRA expression or histone modifications. siRNA SMARTpools
representing a control pool or the indicated gene were transfected into Raji cells using nucleofection. (A) At three days post transfection western
blots for the indicated factor were performed along with b-actin control. (B) mRNA from similar cultures was analyzed by qRT-PCR for CIITA and HLA-
DRA transcripts. The data from four biological replicates was plotted over the siRNA control transfection. (C) Chromatin was isolated from the
indicated siRNA transfected cells at 3 days post transfection and analyzed for the presence of the indicated histone modifications at the WXY box
region of the HLA-DRA gene. The results of three biological replicates were averaged and plotted with respect to the input chromatin. Error bars in B
and C represent the standard error.
doi:10.1371/journal.pone.0037554.g007
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PLoS ONE | www.plosone.org 12 May 2012 | Volume 7 | Issue 5 | e37554Figure 8. CIITA and modified histones are stably bound at the HLA-DRA promoter after IFN-c removal. (A) mRNA levels of CIITA and HLA-
DRA were measured by qRT-PCR after A431 cells were treated with IFN-c for 0 or 24 hrs (black bars), and after IFN-c treated cells were washed and
supplied with IFN-c free media and cultured for an additional 24 to 72 hrs (grey bars). An additional but separate set of experiments were carried out
for 120 hours (clear) and are shown. The results of three independent experiments were averaged and plotted with standard error. (B) ChIP for CIITA
and each indicated histone modification, as well as a negative control IgG were conducted after A431 cells were treated as in A. ChIP assays were
analyzed at the WXY box region. The qRT-PCR and ChIP values for the 0 and 24 hr IFN-c treated samples in the left panels of each set are the same as
those shown in Figure 1 as the data were generated from the same set of experiments and chromatin preparations, and are provided again only for
comparison purposes.
doi:10.1371/journal.pone.0037554.g008
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and PCAF are also capable of acetylating transcription factors.
PCAF was shown to acetylate CIITA and regulate its nuclear
localization [23]. These reports support the notion that while these
KATs are globally recruited to actively transcribed genes, they use
different and/or multiple mechanisms to activate genes.
GCN5, the first KAT identified to be involved in transcriptional
activation, functions as part of the well-characterized yeast SAGA
complex [65]. In vertebrates PCAF shares 75% homology with
GCN5 and both have somewhat redundant functions [66]. Recent
work in metazoans has further divided the SAGA complexes into
STAGA and ATAC, which share a common core of GCN5/
PCAF, ADA3, STAF36, and a homolog of the yeast ADA2, being
either ADA2a in ATAC complexes, or ADA2b in STAGA
complexes [53]. STAGA and ATAC contain other unique
subunits that allow them to function at separate target genes
largely in a mutually exclusive manner [67]. While the results
presented here showed enrichment for ADA2a, a component of
the ATAC complex, but not ADA2b of the STAGA complex at
HLA-DRA promoter and XL4, other components of the STAGA
complex were present. The results presented here suggest other
complexes for GCN5/PCAF may exist or that the components
assemble independently of the larger complexes depending on the
unique activating transcription factors available at each gene.
In sharp contrast to the other coactivators, the binding of
WDR5 in B cells was completely independent of CIITA and
RFX5. This suggests that WDR5 may be recruited to the region
by the WXY box factors prior to CIITA and acts as a docking site
for its partner histone modifying proteins. Although the other
MLL complex proteins, MLL1, ASH2L, RbBP5, and DPY-30
bound to varying levels in the absence of CIITA, their occupancy
increased when CIITA was bound. This suggests that WDR5 is
recruited through multiple mechanisms and potentially multiple
complexes. WDR5 is reported to be present in both the MLL and
ATAC complexes [47,53]. A recent publication showed the NF-Y
complex was able to recruit ASH2L to CCAAT containing
promoters [68]. As NF-Y proteins are also part of the MHC-II
promoter-binding complex, this could partially explain the
CIITA-independent binding of MLL complex components. Also,
a WDR5, ASH2L, and RbBP5 complex was shown to catalyze
H3K4 mono- and di- methylation activity independent of MLL
[69]. By applying a basal level of H3K4 methylation independent
of CIITA, these proteins may function to increase the accessibility
of the chromatin at these sites, which can be modified further with
the recruitment of MLL and other coactivators.
siRNA knockdown of GCN5, MLL1, and WDR5 could not
provide evidence that these factors were essential to HLA-DRA gene
expression.Whilethe data could be interpreted that the components
are not required or are redundant, another interpretation is also
possible. This possibility involves the programming of this gene and
the epigenetic stability of the histone modifications that were placed
following activation. When IFN-c was removed from the inducible
system,thelevelofHLA-DRAwasunaltered despitethe lossofCIITA
transcription. This may be partly due to the stability of the HLA-
DRA mRNA itself. However, the data suggest that this is more likely
a consequence of a number of events, including the presence of
active histone modifications that are stably associated with the
promoter. Albeit reduced, CIITA was also readily detectable at
three and five days post IFN-c removal from the system. Thus, there
is an inherent stability of CIITA binding and the histone
modifications associated with the locus once it is activated.
In summary, the results presented here illustrate the complexity
in activating the HLA-DRA gene and showed that multiple KATs
and KMTs are involved in the process. For histone acetylation, it
is clear that CIITA is critically required for the placement of these
marks. Even with this being the case, some of the factors can be
recruited to the gene in the absence of CIITA, implying that their
recruitment may not in its self be sufficient for them to catalyze
these modifications. For histone methylation, CIITA-dependent
and independent recruitment of factors occurs. However, some of
these factors are active in the absence of CIITA, creating a state in
which this region is open and accessible. Thus, their role may be to
maintain a constitutively accessible state, such that these important
adaptive immune response set of genes can be induced rapidly in
response to infections.
Supporting Information
Figure S1 IFN-c treatment induced the deposition of
active histone modifications throughout the HLA-DRA
gene, plotted with respect to histone H3 density. The data
from Figure 1C were replotted as fold over the histone H3 percent
of input chromatin values for each amplicon as determined by
histone H3 ChIP.
(TIF)
Figure S2 MHC-II expressing B cells have active histone
modifications distributed across the HLA-DRA gene,
plotted with respect to histone H3 density. The data from
Figure 2B were replotted as fold over the histone H3 percent of
input chromatin values for each amplicon as determined by
histone H3 ChIP.
(TIF)
Figure S3 Histone modifying proteins in Raji, RJ2.2.5,
and SJO cells are expressed at similar levels. Nuclear
extracts from Raji, RJ2.2.5, and SJO cells were prepared and
equally loaded on SDS-PAGE, blotted to PVDF membranes and
stained with the indicated antibodies as described in materials and
methods. Molecular weight (MW) are shown.
(TIF)
Figure S4 GCN5 complex component ChIP from IFN-c
treated A431 cells. Dual crosslinking ChIP was performed on
A431 cells 2/+ IFN-c for 24 hours as described in the text of the
manuscript. These data represent the average of three biological
replicates. Asterisks represent data values that were statistically
significant (Student’s t-test p,0.05) when compared to the IgG
control ChIP assays.
(TIF)
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